PHK
DNA icon

Point72 Hong Kong’s Ginkgo Bioworks DNA Stock Holding History

Point72 Hong Kong’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$9K – 515
2022
Q3 		$9K Sell
70
-5,725
-99% -$682K ﹤0.01% 1732
2022
Q2 		$552K Buy
+5,795
New +$707K 0.02% 687

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Point72 Hong Kong's DNA Position: Q4 2022 in Review

Point72 Hong Kong sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 70 shares — an estimated $9K sold.

Point72 Hong Kong first reported a position in DNA in Q2 2022 and held it in 2 quarters. The position peaked at $552K in Q2 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Point72 Hong Kong reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 70 Ginkgo Bioworks shares in Q4 2022, an estimated $9K.
  • Point72 Hong Kong first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 2 quarters.
  • Point72 Hong Kong's Ginkgo Bioworks position peaked at $552K in Q2 2022.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.